IMMUNOLOGICAL BASIS OF ENDOTOXIN-INDUCED TUMOR REGRESSION - REQUIREMENT FOR T-CELL-MEDIATED IMMUNITY

被引:104
|
作者
BERENDT, MJ
NORTH, RJ
KIRSTEIN, DP
机构
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1978年 / 148卷 / 06期
关键词
D O I
10.1084/jem.148.6.1550
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:1550 / 1559
页数:10
相关论文
共 50 条
  • [21] Transient deficiencies of T-cell-mediated immunity in the neonate
    Randolph, David A.
    Lewis, David B.
    HOT TOPICS IN INFECTION AND IMMUNITY IN CHILDREN III, 2006, 582 : 55 - 69
  • [22] NOTCH Signaling in T-Cell-Mediated Anti-Tumor Immunity and T-Cell-Based Immunotherapies
    Kelliher, Michelle A.
    Roderick, Justine E.
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [23] GLUCOCORTICOID-MEDIATED INHIBITION OF ENDOTOXIN-INDUCED INTRATUMOR TUMOR NECROSIS FACTOR PRODUCTION AND TUMOR HEMORRHAGIC NECROSIS AND REGRESSION
    NORTH, RJ
    HAVELL, EA
    JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03): : 703 - 710
  • [24] A Myeloid Cell Population Induced by Freund Adjuvant Suppresses T-cell-mediated Antitumor Immunity
    Wang, Zibing
    Jiang, Jing
    Li, Zhiguang
    Zhang, Jinhua
    Wang, Hui
    Qin, Zhihai
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (02) : 167 - 177
  • [25] ENDOTOXIN-INDUCED TUMOR-REGRESSION DEPENDS ON PRESENCE OF SUBTHERAPEUTIC NUMBERS OF TUMOR-SENSITIZED T-CELLS
    DIGIACOMO, A
    NORTH, RJ
    EOS-RIVISTA DI IMMUNOLOGIA ED IMMUNOFARMACOLOGIA, 1986, 6 (03): : 238 - 238
  • [26] DEVELOPMENT OF SPECIFIC T-CELL-MEDIATED IMMUNITY WITHIN FBL-3 SOLID TUMOR
    HONG, JX
    FEDERATION PROCEEDINGS, 1982, 41 (03) : 415 - 415
  • [27] Alterations of T-cell-mediated immunity in acute myeloid leukemia
    Li, Zhuoyan
    Philip, Mary
    Ferrell, P. Brent
    ONCOGENE, 2020, 39 (18) : 3611 - 3619
  • [28] T-CELL-MEDIATED IMMUNITY AND TISSUE-DAMAGE IN THE GUT
    MACDONALD, TT
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 1993, 7 (02): : 87 - 90
  • [30] Alterations of T-cell-mediated immunity in acute myeloid leukemia
    Zhuoyan Li
    Mary Philip
    P. Brent Ferrell
    Oncogene, 2020, 39 : 3611 - 3619